<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05084846</url>
  </required_header>
  <id_info>
    <org_study_id>H-21011835</org_study_id>
    <nct_id>NCT05084846</nct_id>
  </id_info>
  <brief_title>InFLUenza and the HEART An Investigation Into the Acute and Lasting Cardiac Effects of Influenza Infection</brief_title>
  <acronym>FluHeart</acronym>
  <official_title>Influenza and the Heart: An Investigation Into the Acute and Lasting Cardiac Effects of Influenza Infection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Gentofte, Copenhagen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Gentofte, Copenhagen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      &quot;Influenza and the Heart: An investigation into the acute and lasting cardiac effects of&#xD;
      influenza infection&quot; we aim to assess the mechanisms for cardiovascular disease in patients&#xD;
      suffering an acute influenza infection. The project will be carried out by creating a&#xD;
      prospective clinical cohort study of consecutive patients hospitalized at Herlev &amp; Gentofte&#xD;
      University Hospital with a laboratory confirmed influenza.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 1, 2021</start_date>
  <completion_date type="Anticipated">March 31, 2025</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiovascular complications</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>In-hospital mortality</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Cardiac dysfunction</measure>
    <time_frame>3 years</time_frame>
    <description>Defined by impaired echocardiographic parameters and elevated cardiac biomarkers - NT&#xD;
- pro&#xD;
- BNP annd hs&#xD;
- TNT</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Elevated biomarkers of infection/inflammation</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Pulmonary embolisms diagnosed with CT thorax angiography</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Influenza</condition>
  <condition>Cardiovascular Complication</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Hospitalized patients with laboratory confirmed influenza&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All patients hospitalized at Herlev &amp; Gentofte University Hospital with a laboratory&#xD;
             confirmed diagnosis of influenza&#xD;
&#xD;
          -  &gt; 18 years of age&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Persons not able to cooperate&#xD;
&#xD;
          -  Persons unable to understand and sign &quot;informed consent&quot;&#xD;
&#xD;
          -  Pregancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 6, 2021</study_first_submitted>
  <study_first_submitted_qc>October 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 20, 2021</study_first_posted>
  <last_update_submitted>October 6, 2021</last_update_submitted>
  <last_update_submitted_qc>October 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Gentofte, Copenhagen</investigator_affiliation>
    <investigator_full_name>Tor Biering-SÃ¸rensen</investigator_full_name>
    <investigator_title>MD, PhD, MPH</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Influenza, Human</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

